L2M_Business Strategy for CELLECT’s Research and Commercialization

Despite advancements in women’s health diagnostics, cervical cancer screening rates remain critically low due to the invasive nature of traditional collection methods like Pap smears and self-swabs. CELLECT is pioneering a non-invasive, nanotechnology-enabled collection device—the CELLECTPad—that passively captures high-quality cervical and epithelial cells during menstruation. By removing the discomfort and accessibility barriers of existing methods, CELLECT aims to transform the landscape of gynecological screening and reproductive health research.

Faculty Supervisor:

Marc Aucoin

Student:

Partner:

DMZ Ventures Inc

Discipline:

Engineering

Sector:

Nanotechnology; Biotechnology

University:

University of Waterloo

Program:

Business Strategy Internship

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects